Comparative evaluation of the COBAS AmpliPrep/COBAS TaqMan HIV type 1 test (CAP/CTM) and VERSANT HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China

AIDS Research and Human Retroviruses

Volumn 24, Issue 11, 2008, Pages 1365-1373

  Xu, Sihong ^a   Song, Aijing ^a   Nie, Jianhui ^a   Li, Xiuhua ^a   Li, Jingyun ^b   Bao, Zuoyi ^b   Wang, Youchun ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NEVIRAPINE; ZIDOVUDINE;

ACCURACY; ARTICLE; CHINA; CLADISTICS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

CHINA; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 57049182536     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0005     Document Type: Article

References (22)

1. Lal RB, Chakrabarti S, and Yang C: Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy and vaccine development. Indian J Med Res 2005;121:287-314.
2. Fraf M, Shao Y, Zhao Q, Seidl T, Kostler J, Wolf H, and Wagner R: Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B′-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses 1998;14:285-288.
3. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J, Wagner R, Wolf H, Shao Y, Lai S, Beyrer C, and Yu X-F: A recent outbreak of human immunodeficiency virus type 1 in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000;74:11286-11295.
4. Swanson P, de Mendoza C, Joshi Y, Golden A, Hodinka RL, Soriano V, Devare SG, and Hackett J Jr: Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 2005;43:3860-3868.
5. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, and Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
6. Vandamme AM, Dooren SV, Kok W, Goubau P, Fransen K, Kievits T, Schmit JC, Clercq ED, and Desmyter J: Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 1995;52:121-132.
7. Kern D, Collins M, Fultz T, Detmer J, Hamren S, Peterkin JJ, Sheridan P, Urdea M, White R, Yeghiazarian T, and Todd J: An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3196-3202.
8. Murphy DG, Cote L, Fauvel M, Rene P, and Vincelette J: Multicenter comparison of Amplicor 1.5 COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2000;38:4034-4041.
9. Gibson UE, Heid CA, and Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
10. Antunes R, Figueiredo S, B'artolo I, Pinheiro M, Rosado L, Soares I, et al.: Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J Clin Microbiol 2003;41:3361-3367.
11. Highbarger HC, Alvord WG, Jiang MK, Shah AS, Metcalf JA, Lane HC, et al.: Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples. J Clin Microbiol 1999;37:3612-3614.
12. Nolte FS, Boysza J, Thurmond C, Clark WS, and Lennox JL: Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998;36:716-720.
13. Anastassopoulou CG, Touloumi G, Katsoulidou A, Atzitheodorou H, Pappa M, Paraskevis D, et al.: Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Virol Methods 2001;91:67-74.
14. Elbeik T, Alvord WG, Trichavaroj R, de Souza M, Dewar R, Brown A, Chernoff D, Michael NL, Nassos P, Hadley K, and Ng VL: Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Montor version 1.5. J Acquir Immune Defic Syndr 2002;29:330-339.
15. Galli R, Merrick L, Friesenhahn M, and Ziermann R: Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens. J Clin Virol 2005;34:245-252.
16. Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, Vliet RV, and Babiel R: Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® system. J Clin Virol 2007;38: 304-312.
17. Katsoulidou A, Petrodaskalaki M, Sypsa V, Papachristou E, Anastassopoulou CG, et al.: Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays-LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5. J Virol Methods 2006;131:168-174.
18. Gomes P, Palma AC, Cabanas J, Abecasis A, Carvalho AP, et al.: Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes. J Virol Methods 2006;135:223-228.
19. Gardner SN, Kuczmarski TA, Vitalis EA, and Slezak TR: Limitations of TaqMan PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E, viruses and human immunodeficiency virus. J Clin Microbiol 2003;41:2417-2427.
20. Wang Y, Song A, Xu S, Li X, Chong H, Zhao C, et al.: The impact of HIV-1 genetic diversity in China on the measurement of viral load. J Med Virol 2008;80:1-8.
21. Bland JM and Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
22. Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, Vliet RV, and Babiel R: Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® system. J Clin Virol 2007;38:304-312.